ClinicalTrials.govpublic full text
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
recurrent diffuse large b-cell lymphoma, recurrent diffuse large b-cell lymphoma, not otherwise specified, recurrent grade 3b follicular lymphoma, recurrent high grade b-cell lymphoma, recurrent primary mediastinal large b-cell lymphoma, recurrent transformed indolent b-cell non-hodgkin lymphoma to diffuse large b-cell lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 195320
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.